Cannabis Law Report

FEBRUARY 3, 2021

The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 billion first appeared on Cannabis Law Report. … Read More.

Pharmaceutical 85

Pharmaceutical Law Cannabis 85

Cannabis Law Report

MARCH 18, 2021

Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.

Pharmaceutical 98

Pharmaceutical Cannabis 98

Cannabis Law Report

JANUARY 17, 2023

Celadon Pharmaceuticals PLC shares rose on Monday after the company said that its Midlands facility has been registered for the good manufacturing practice standard by the U.K.’s The UK-based pharmaceutical company focused on […]. ’s health watchdog for the production of its medicinal cannabis. pence, or 11%, at 57.0

Pharmaceutical 52

Pharmaceutical Medicine Cannabis 52

Cannabis Law Report

MAY 12, 2021

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More.

Pharmaceutical 75

Pharmaceutical Business 75

Cannabis Law Report

OCTOBER 20, 2020

Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More. The post Prohibition Partners (UK) Publish "The Pharmaceutical Cannabis Report" first appeared on Cannabis Law Report.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis Law 59

Cannabis Law Report

MAY 12, 2020

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

Pharmaceutical 98

Pharmaceutical Cannabinoids 98

Cannabis Law Report

JANUARY 23, 2023

VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court. The insolvency declaration judgment, requested by one of the company’s more than 80 creditors, was handed down on 23 November 2022 and has now become final, in January 2023.

Pharmaceutical 52

Pharmaceutical Access Cannabis Compliance 52

Cannabis Law Report

MAY 26, 2023

Multinational operator to supply pharmaceutical-grade CBD extract for European patients TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc.

Pharmaceutical 52

Pharmaceutical Extraction Medicine CBD 52

Cannabis Law Report

DECEMBER 12, 2020

Clever Leaves expands global capabilities and development of market specific pharmaceutical products. The post Clever Leaves Successfully Delivers First Shipment of EU GMP certified Cannabis derived Pharmaceuticals from Colombia to Germany first appeared on Cannabis Law Report. NEW YORK, Dec.

Pharmaceutical 84

Pharmaceutical Law Cannabis 84

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Cannabis Law Report

OCTOBER 25, 2022

The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. The company signed a definitive agreement with Franchise Global Health, which has principal operations in Europe’s largest economy.

Pharmaceutical 59

Pharmaceutical Cannabis 59

Cannabis Law Report

JUNE 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

Cannabis Law Report

FEBRUARY 23, 2022

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research.

Pharmaceutical 52

Pharmaceutical Research and Development Extraction Cannabinoids 52

Cannabis Life Network

JUNE 25, 2022

Cannabinoid and nicotine products differ from one another — from ‘cultivation’ to their pharmaceutical effects. Will the FDA’s recent ban on products by Juul indicate future vape laws regarding minor cannabinoids, such as delta 8 THC? Certain governments have, however, regulated the two hand in hand. Newly […].

Vaping 80

Vaping THC Law Pharmaceutical 80

Cannabis Law Report

NOVEMBER 23, 2020

The post MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics first appeared on Cannabis Law Report. 22 Nov – Blurb… Since 2019, Medicinal Cannabis Clinics has facilitated over 4,000 medical consultations with pre-screened eligible patients and has shown continued month-on-month growth.…

Pharmaceutical 59

Pharmaceutical Medicine Patients Cannabis 59

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Cannabis Law Report

MARCH 20, 2021

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

Pharmaceutical 98

Pharmaceutical Programs Cannabis 98

Cannabis Law Report

JUNE 2, 2021

The following provides a summary of the current status of laws applicable to use of marijuana and its derivatives in Idaho. Idaho law classifies marijuana and many of its derivatives as Schedule I controlled substances that cannot be prescribed, manufactured, distributed, or possessed for any reason. Pharmaceutical Grade CBD Oil.

Law 103

Law Marijuana Oil Pharmaceutical 103

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. ” “We continue to tweak the law regarding cannabis oils. ” Virginia Senator Siobhan Dunnavant.

Law 260

Law Patients Access Oil 260

Cannabis Law Report

NOVEMBER 25, 2022

Radio NZ reports… A local law approving the medicinal use of cannabis has been approved by the French Polynesian assembly. The law also authorises the agricultural production of cannabis and hemp for industrial purposes, in particular pharmaceutical, within the framework of regulations under the International Narcotics Drugs convention.

Medicine 52

Medicine Law Pharmaceutical Agriculture 52

Cannabis Law Report

MARCH 26, 2022

Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. ” ‘Strategic investment’ Jazz Pharmaceuticals currently manufactures the extract, active pharmaceutical ingredients and the formulated drug products at KSP, occupying 12 buildings with more than 400 employees.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

MAY 6, 2021

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More.

Pharmaceutical 59

Pharmaceutical Business 59

Cannabis Law Report

MAY 31, 2023

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Patients 52

Cannabis Law Report

APRIL 13, 2021

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis 59

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. Eastern time on the Investors section of Anebulo’s website. Scott Anderson.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Business 52

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. Eurofins is a global leader in food, environment, and pharmaceutical product testing.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Except as required by federal securities law, Anebulo Pharmaceuticals undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

JUNE 28, 2020

The mycology-focused company has signed an agreement with Applied Pharmaceutical Innovation (API), … Read More. Mydecine ( MYCO.CN ) ( NLBIF ) is quickly upping its fungi authority.

Pharmaceutical 59

Pharmaceutical Business Law 59

The Cannigma

JUNE 1, 2021

Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. The post Cannabis laws in France appeared first on The Cannigma.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

AUGUST 22, 2021

. “Looking at the industry as it is growing, we are seeing the emergence of a brand-new sector: the psycheceutical industry, which merges the best of psychedelics and the best of pharmaceuticals. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Psycheceutical, Inc.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

The Cannigma

DECEMBER 4, 2022

Another draft law was introduced in 2019 to expand the program; as of 2022, it was still in draft in a chamber of government. Patients can be prescribed medical marijuana in the form of pharmaceuticals, like Sativex. As of April 2022, the law is still in draft in the Chamber of Deputies. Possible penalties. CBD regulations.

Law 59

Law Seed-To-Sale Programs Tincture 59

The Cannigma

MAY 1, 2023

Let’s take a closer look at the current state of cannabis laws in Ghana. It is classified as a narcotic drug under the country’s Narcotic Drugs (Control, Enforcement, and Sanctions) Law, 1990 (PNDC Law 236). This law makes it illegal to cultivate, produce, traffic, or use any narcotic drug, including cannabis.

Law 52

Law Cultivation Treatment Programs 52

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Except as required by federal securities law, Anebulo Pharmaceuticals undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Cannabis Law Report

DECEMBER 3, 2020

3, 2020 /PRNewswire/ — Pure Jamaican Limited , provider of pharmaceutical cannabinoids, genetics and consumer packaged goods products in large volumes for … Read More. MIAMI , Dec.

Pharmaceutical 64

Pharmaceutical Legislation Packaging Cannabinoids 64

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84